Dental Care Clinics in Holt, MI Accepting Medicare
7 Dental Care Clinics found. Showing 1 - 7
 Terence E Mchugh Dds Plc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 4378 Holt Rd Ste 2, Holt, MI 48842 Phone: 517-694-2412 Fax: 517-694-0405 |
Susan S Maples Dds, Msba, Pllc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 2101 N. Aurelius Rd Ste 1, Holt, MI 48842 Phone: 517-694-0353 |
Kelly Anne Snyder, Dds, P.c. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 2101 Aurelius Rd, Suite 3, Holt, MI 48842 Phone: 517-694-4700 |
Holt Family Dentistry Dentist Medicare: Not Enrolled in Medicare Practice Location: 2205 Cedar St, Holt, MI 48842 Phone: 517-694-2501 Fax: 517-694-2637 |
Edward C Liu Dds Pllc Clinic/Center - Dental Medicare: Medicare Enrolled Practice Location: 2123 Aurelius Rd, Holt, MI 48842 Phone: 517-699-2985 Fax: 517-699-2205 |
Total Health Dentistry Dentist Medicare: Not Enrolled in Medicare Practice Location: 2101 Aurelius Rd Ste 1, Holt, MI 48842 Phone: 517-694-0353 Fax: 517-694-2001 |
Blair Family Dentistry Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 2500 Cedar St, Holt, MI 48842 Phone: 517-694-3111 Fax: 517-694-9202 |
News Archive
ElsaLys Biotech announces first round of financing from Transgene and Sofimac Partners
ElsaLys Biotech, which specializes in the development of therapeutic monoclonal antibodies, announces a first round of financing of 2.1M€ from the biopharmaceutical company Transgene and the investment fund Sofimac Partners.
PNP Therapeutics granted FDA orphan drug designation for Gedeptin
PNP Therapeutics Inc. announced today the Food and Drug Administration has granted orphan drug status to Gedeptin, the Company's lead product candidate (adenoviral vector expressing E. coli purine nucleoside phosphorylase gene) for the intratumoral treatment of anatomically accessible oral and pharyngeal cancers, including cancers of the lip, tongue, gum, floor of mouth, salivary gland and other oral cavities.
Researchers present new method of wirelessly recharging medical device batteries with ultrasound
Human beings don't come with power sockets, but a growing numbers of us have medical implants that run off electricity. To keep our bionic body parts from powering down, a group of Arizona researchers is developing a safe, noninvasive, and efficient means of wireless power transmission through body tissue.
Researchers develop simple, flexible technique for early cancer diagnosis
Earlier discovery of cancer and greater precision in the treatment process are the objectives of a new method developed by researchers at Sahlgrenska Academy and Boston University.
Argos Therapeutics announces presentations on sCD83 protein capabilities at 2010 American Transplant Congress
Argos Therapeutics today announced two oral presentations detailing data on its soluble CD83 (sCD83) protein program at the 2010 American Transplant Congress, held May 1-5 in San Diego. The data, which were produced by Argos in collaboration with scientists from the University of Western Ontario, demonstrate that sCD83 is capable of inducing immune system tolerance to transplant grafts and suppressing an anti-donor antibody response, via a multi-faceted mechanism-of-action that impacts B and T cells, as well as dendritic cells.
› Verified 7 days ago